Telix Pharmaceuticals and Atlab Pharma Conclude Therapeutic Product Development Agreement for Prostate Cancer
Telix is pleased to announce the completion of a product collaboration and purchase option agreement with Atlab Pharma SAS...
Read moreLatest News
Category: News
Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia
Telix is pleased to announce a product development partnership with Therapeia GmbH & Co KG...
Read more
Wilex Signs Antibody License Agreement With Telix Pharmaceuticals Limited
News,
Telix is delighted to have established this licensing agreement with Wilex for an important product with the potential to significantly impact cancer...
Read more